Are pharmacokinetic approaches feasible for treatment of cocaine addiction and overdose? - PubMed (original) (raw)

Editorial

Are pharmacokinetic approaches feasible for treatment of cocaine addiction and overdose?

Fang Zheng et al. Future Med Chem. 2012 Feb.

Abstract

“… we discuss the main challenges for developing therapeutic treatment of cocaine addiction and explain why pharmacokinetic approaches, particularly those based on our recently developed efficient cocaine-metabolizing enzymes, are feasible for treatment of cocaine addiction and overdose.”

PubMed Disclaimer

Conflict of interest statement

Competing interests disclosure

The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

References

1. United Nations Office on Drugs and Crime (UNODC) United Nations Publication. 2011. World Drug Report 2011. Sales No. E.11.XI.10.
1. Gorelick DA, Gardner EL, Xi ZX. Agents in development for the management of cocaine abuse. Drugs. 2004;64:1547–1573. - PubMed
1. Pan Y, Gao D, Yang W, Cho H, Yang GF, Tai HH, Zhan CG. Computational redesign of human butyrylcholinesterase for anti-cocaine medication. Proc Natl Acad Sci USA. 2005;102:16656–16661. - PMC - PubMed
1. Zheng F, Yang W, Ko MC, Liu J, Cho H, Gao D, Tong M, Tai HH, Woods JH, Zhan CG. Most efficient cocaine hydrolase designed by virtual screening of transition States. J Am Chem Soc. 2008;130:12148–12155. - PMC - PubMed
1. Xue L, Ko MC, Tong M, Yang W, Hou S, Zheng F, Woods JH, Tai HH, Zhan CG. Rational design, preparation and characterization of high-activity mutants of human butyrylcholinesterase against (-)-cocaine. Mol Pharmacol. 2011;79:290–297. - PMC - PubMed

Are pharmacokinetic approaches feasible for treatment of cocaine addiction and overdose? - PubMed (original) (raw)